technetium has been researched along with Neuroendocrine Tumors in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Briganti, V; Cuccurullo, V; Di Stasio, GD; Mansi, L | 1 |
| Kanduluru, AK; Low, PS; Srinivasarao, M; Wayua, C | 1 |
| Celler, A; Chamoiseau, S; Shcherbinin, S | 1 |
| Camargo, EE; Cantoni, S; Corradi, G; Costa, FP; de Almeida Filho, JG; de Oliveira Santos, A; Etchebehere, EC; Gumz, B; Hoff, PG; Ichiki, WA; Vicente, A | 1 |
| Li, G; Low, PS | 1 |
| Azorín-Vega, E; Ferro-Flores, G; Ocampo-García, BE; Orocio-Rodríguez, E; Ramírez, Fde M; Sánchez-García, FM; Santos-Cuevas, CL | 1 |
| Berendzen, A; Carmack, T; Gallazzi, F; Hennkens, HM; Jurisson, SS; Lewis, MR; Papagiannopoulou, D; Radford, L; Watkinson, L | 1 |
| Araujo, EB; Barboz, MF; Buchpiguel, CA; Melo, IB; Mengatti, J; Muramoto, E; Silva, CP; Ueda, LT | 1 |
| Ballinger, JR; Solanki, KK | 1 |
| Bergmann, F; Giesel, FL; Haberkorn, U; Kratochwil, C; Mafomane, MP; Mehndiratta, A; Schemmer, P; Zechmann, CM | 1 |
| Maina, T; Nock, B | 1 |
| Camera, L; Del Vecchio, S; Ibello, F; Pellegrino, T; Quarantelli, M; Salvatore, M | 1 |
| Shapiro, B | 1 |
3 review(s) available for technetium and Neuroendocrine Tumors
| Article | Year |
|---|---|
Gamma Emitters in Pancreatic Endocrine Tumors Imaging in the PET Era: Is there a Clinical Space for 99mTc-peptides?
Topics: Animals; Gamma Rays; Humans; Mice; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Organotechnetium Compounds; Pancreatic Neoplasms; Peptides; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Somatostatin; Technetium | 2019 |
Tetraamine-coupled peptides and resulting (99m)Tc-radioligands: an effective route for receptor-targeted diagnostic imaging of human tumors.
Topics: Amines; Chelating Agents; Clinical Trials as Topic; Diagnostic Imaging; Humans; Ligands; Neuroendocrine Tumors; Oligopeptides; Pancreatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Receptors, Peptide; Technetium | 2012 |
Radiolabeled somatostatin analogs in the diagnosis and staging of neuroendocrine tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Humans; Indium Radioisotopes; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Technetium | 2003 |
10 other study(ies) available for technetium and Neuroendocrine Tumors
| Article | Year |
|---|---|
Evaluation of a Neurokinin-1 Receptor-Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging.
Topics: Animals; Chelating Agents; False Positive Reactions; Female; HEK293 Cells; Humans; Ligands; Mice; Mice, Nude; Neoplasm Transplantation; Neuroendocrine Tumors; Peptides; Receptors, Neurokinin-1; Single Photon Emission Computed Tomography Computed Tomography; Somatostatin; Technetium; Tomography, X-Ray Computed | 2020 |
Simulation-based reconstruction of absolute activities from the (99m)Tc/(111)In dual-isotope SPECT/CT: phantom experiments and imaging of neuroendocrine tumors.
Topics: Humans; Image Processing, Computer-Assisted; Indium Radioisotopes; Multimodal Imaging; Neuroendocrine Tumors; Phantoms, Imaging; Positron-Emission Tomography; Technetium; Tomography, X-Ray Computed | 2013 |
68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
Topics: Adult; Aged; Algorithms; Biopsy; Female; Humans; Hydrazines; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Nicotinic Acids; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Technetium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Synthesis and evaluation of a ligand targeting the somatostatin-2 receptor for drug delivery to neuroendocrine cancers.
Topics: Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Endocytosis; Ligands; Mice; Microscopy, Confocal; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Rhodamines; Technetium; Tissue Distribution | 2015 |
Two Novel Nanosized Radiolabeled Analogues of Somatostatin for Neuroendocrine Tumor Imaging.
Topics: Animals; Cell Line, Tumor; Dendrimers; Gold; Male; Metal Nanoparticles; Mice; Mice, Nude; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Rats; Somatostatin; Technetium; Tissue Distribution | 2015 |
Synthesis and evaluation of a
Topics: Animals; Chemistry Techniques, Synthetic; Female; Isotope Labeling; Mice; Neuroendocrine Tumors; Peptides; Radiochemistry; Receptors, Somatostatin; Rhenium; Single Photon Emission Computed Tomography Computed Tomography; Technetium; Tissue Distribution | 2017 |
Tecnetium-99m as alternative to produce somatostatin-labeled derivatives: comparative biodistribution evaluation with 111In-DTPA-octreotide.
Topics: Animals; Intestines; Kidney; Ligands; Liver; Mice; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Peptides; Quality Control; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Technetium; Time Factors; Tissue Distribution | 2010 |
What will be required to bring ⁶⁸Ga-labelled peptides into routine clinical use?
Topics: Gallium Radioisotopes; Humans; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Practice Guidelines as Topic; Radionuclide Generators; Radiopharmaceuticals; Technetium; Tomography, X-Ray Computed; United Kingdom | 2011 |
Cancer with unknown primary: finding a needle in a hay stack.
Topics: Humans; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Technetium; Tomography, X-Ray Computed | 2012 |
Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Topics: 3-Iodobenzylguanidine; Administration, Inhalation; Autoimmune Diseases; Biogenic Amines; Cardiomyopathies; Combined Modality Therapy; Heart; Humans; Indium Radioisotopes; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Lung; Neuroendocrine Tumors; Octreotide; Peptides; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Sympathetic Nervous System; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |